M&A Deal Summary

Merck Acquires Viralytics

On February 21, 2018, Merck acquired life science company Viralytics for 502M AUD

Acquisition Highlights
  • This is Merck’s 15th transaction in the Life Science sector.
  • This is Merck’s 23rd largest (disclosed) transaction.
  • This is Merck’s 1st transaction in Australia.

M&A Deal Summary
Date 2018-02-21
Target Viralytics
Sector Life Science
Buyer(s) Merck
Deal Type Add-on Acquisition
Deal Value 502M AUD
Advisor(s) Lazard Ltd. (Financial)
McCullough Robertson (Legal)

Target

Viralytics

Sydney, Australia
Viralytics Ltd. is focused on the development and commercialization of oncolytic immunotherapies that harness the power of specific viruses to preferentially infect and kill cancer cells. Viralytics is based in Sydney, Australia.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Merck

Rahway, New Jersey, United States
Category Company
Founded 1891
Sector Life Science
Employees70,000
Revenue 60.1B USD (2023)
DESCRIPTION
Merck office in Palo Alto, California.
Merck office in Palo Alto, California.

Merck is a global healthcare company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The Company’s operations are comprised of four operating segments. These include Pharmaceutical, Animal Health, Consumer Care and Alliances. Merck's Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. Vaccine products consist of preventive pediatric, adolescent and adult vaccines, primarily administered at physician offices. The Company also has animal health operations that discover, develop, manufacture and market animal health products, including vaccines, which the Company sells to veterinarians, distributors and animal producers. Additionally, the Company has consumer care operations that develop, manufacture and market over-the-counter, foot care and sun care products. Merck was established in 1891 and is based in Rahway, New Jersey.

DEAL STATS #
Overall 17 of 35
Sector (Life Science) 15 of 32
Type (Add-on Acquisition) 17 of 33
Country (Australia) 1 of 1
Year (2018) 1 of 2
Size (of disclosed) 23 of 27
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-07-11 StayWell

Yardley, Pennsylvania, United States

Staywell is a health empowerment company that enables populations to improve health outcomes through the science of behavior change. Staywell was founded in 1978 and is headquartered in St. Paul, Minnesota.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-04-05 C3i Solutions

Horsham, Pennsylvania, United States

C3i Solutions is multi-channel customer engagement services provider, specializing in global, high-touch consumer, patient, and end-user management. C3i Solutions is based in Horsham, Pennsylvania.

Sell -
Mergr

Product

Company

Legal